NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Assessing RadNet (RDNT) Valuation After Share Resale Prospectus Spurs 3% Pullback

RadNet (RDNT) slipped about 3% after it filed a prospectus supplement tied to its shelf registration, clearing the way for certain existing holders to potentially resell roughly 73,500 shares of common stock. See our latest analysis for RadNet. The pullback to a share price of $78.59, with a 1 day share price return of around negative 3 percent on the resale prospectus news, comes after a solid 90 day share price return and a powerful three year total shareholder return. This suggests...
NasdaqGS:NTRS
NasdaqGS:NTRSCapital Markets

Northern Trust (NTRS): Revisiting Valuation After New CIO Appointment and AJ Bell Servicing Mandate

Northern Trust (NTRS) just tightened its focus on wealth and asset servicing, naming Eric Freedman Chief Investment Officer for Wealth Management and winning a sizable servicing mandate from UK platform AJ Bell. See our latest analysis for Northern Trust. These leadership and client wins are landing against a solid backdrop, with the share price delivering a year to date share price return of 29.34 percent and a robust 5 year total shareholder return of 72.15 percent. This suggests momentum...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx (WGS) Valuation After Q3 2025 Revenue Beat, Guidance Raise and Fresh Support From ARK Invest

GeneDx Holdings (WGS) just delivered a Q3 2025 update that combined an earnings per share miss with a revenue beat, then raised its 2025 outlook, drawing fresh support from analysts and ARK Invest. See our latest analysis for GeneDx Holdings. The latest earnings surprise and ARK’s incremental buying come after a powerful run, with a roughly 100% year to date share price return and a triple digit 1 year total shareholder return. This suggests momentum is still very much intact despite recent...
SEHK:6855
SEHK:6855Biotechs

Revisiting Ascentage Pharma Group International (SEHK:6855)’s Valuation After Its Strong One-Year Share Price Gain

Ascentage Pharma Group International (SEHK:6855) has quietly outperformed over the past year, and with shares up roughly 56% in that time, investors are starting to revisit the story behind this clinical stage biotech. See our latest analysis for Ascentage Pharma Group International. The stock has been choppy in recent months, with a 1 day share price return of 4.44 percent and a 90 day share price return of minus 19.91 percent. However, a 1 year total shareholder return of 55.76 percent...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

Should Willis Towers Watson’s New Radar Fusion Underwriting Platform (WTW) Require Action From Investors?

Earlier this week, Willis Towers Watson launched Radar Fusion, a cloud-native commercial underwriting platform for the U.S. market that automates simple risks, consolidates internal and external data, and gives underwriters real-time analytics and pricing insights, with plans to expand to additional regions. The product is positioned as an integrated extension of WTW’s Radar analytics suite, aiming to boost underwriting productivity and profitability by automating routine tasks while keeping...
NYSE:PRIM
NYSE:PRIMConstruction

Will Zacks’ Upgraded Growth View and EPS Forecasts Change Primoris Services' (PRIM) Narrative?

In recent days, Primoris Services was highlighted by Zacks with a top Rank and favorable Growth Score, reflecting analysts’ upgraded expectations for its current-year earnings. This recognition, combined with earnings estimates that now point to significantly faster EPS expansion than the broader industry, suggests analysts see strengthening growth momentum in the company’s near-term fundamentals. We’ll now explore how Primoris’s upgraded growth outlook and upward earnings estimate...
NYSE:GLW
NYSE:GLWElectronic

The Bull Case For Corning (GLW) Could Change Following AI-Driven Optical Profit Surge - Learn Why

Earlier this week, Corning reported stronger-than-expected third-quarter results, with core sales and earnings rising as its optical communications business grew rapidly on the back of AI-related demand. With optical communications now generating more than half of Corning’s core profit, AI infrastructure has become a central driver of the company’s earnings mix. We’ll now explore how Corning’s AI-fueled optical communications growth could reshape its existing investment narrative for...
NasdaqGM:EH
NasdaqGM:EHAerospace & Defense

Does Bangkok Pilotless Flights Milestone With Regulator Onboard Change The Bull Case For EHang (EH)?

EHang Holdings Limited reported third-quarter 2025 sales of CNY 92.47 million with a wider net loss of CNY 82.16 million, while maintaining its full-year 2025 revenue guidance of around CNY 500 million. A separate milestone came from Bangkok, where EHang’s EH216-S completed high-profile urban human-carrying flights under Thailand’s AAM Sandbox Initiative, with the Thai civil aviation chief personally experiencing the pilotless aircraft. We’ll now examine how this Bangkok urban flight...
NasdaqGS:JAMF
NasdaqGS:JAMFSoftware

Jamf (JAMF) Valuation Check After Flat Week and Recent 90-Day Share Price Rebound

Jamf Holding (JAMF) has been drifting quietly, with shares roughly flat over the past week but still well below their past year levels, which sets up an interesting value conversation. See our latest analysis for Jamf Holding. That quiet week sits in the shadow of a much tougher stretch, with the share price at $12.97 still reflecting a negative year to date share price return and a weak multi year total shareholder return, even after a strong 90 day share price rebound that hints momentum...